Achieve Life Sciences, Inc.ACHVNASDAQ
Loading
SG&A Expenses Over TimeExpanding
Percentile Rank100
3Y CAGR+43.7%
5Y CAGR+33.1%
Studio
Year-over-Year Change

Selling, general, and administrative expenses

3Y CAGR
+43.7%/yr
vs +11.5%/yr prior
5Y CAGR
+33.1%/yr
Recent acceleration
Acceleration
+32.2pp
Accelerating
Percentile
P100
Near historical high
vs 5Y Ago
4.2x
Strong expansion
Streak
6 yr
Consecutive growthExpanding
PeriodValueYoY Change
TTM$31.82M+95.8%
2024$16.25M+42.1%
2023$11.44M+6.7%
2022$10.72M+17.5%
2021$9.13M+19.9%
2020$7.61M+11.1%
2019$6.85M-1.3%
2018$6.95M+96.7%
2017$3.53M-60.5%
2016$8.93M-